Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Picot, Joanna"'
Autor:
Picot, Joanna, Shepherd, Jonathan, Kavanagh, Josephine, Cooper, Keith, Harden, Angela, Barnett-Page, Elaine, Jones, Jeremy, Clegg, Andrew, Hartwell, Debbie, Frampton, Geoff K.
Publikováno v:
Health Education Research, 2012 Jun 01. 27(3), 495-512.
Externí odkaz:
https://www.jstor.org/stable/45110884
Autor:
Cooper, Keith, Tikhonova, Irina, Woods, Lois, Hazell, Lorna, Ribeiro, Ines, Picot, Joanna, Scott, David Alexander, Shepherd, Jonathan
This report is a critique of the company’s submission (CS) to NICE from Janssen-Cilag Ltd on the clinical effectiveness and cost effectiveness of apalutamide (Erleada®) for the treatment of metastatic hormone-sensitive prostate cancer and non-meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______348::08e77ed55427fc6db029549744db3fbd
https://eprints.soton.ac.uk/453979/
https://eprints.soton.ac.uk/453979/
Autor:
Kalita, Neelam, Pickett, Karen, Lord, Joanne, Frampton, Geoffrey, Yao, G. Lily, Picot, Joanna
To appraise the clinical and cost effectiveness of daratumumab in combination with bortezomib and dexamethasone, within its marketing authorisation, for treating relapsed or refractory multiple myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______348::f296844ef2ef42105055f21db2c078f5
https://eprints.soton.ac.uk/424711/
https://eprints.soton.ac.uk/424711/
To appraise the clinical and cost effectiveness of sofosbuvir velpatasvir voxilaprevir within its marketing authorisation for treating chronic hepatitis C.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______348::1e0544028063763b9bb6c50df367ae58
https://eprints.soton.ac.uk/418938/
https://eprints.soton.ac.uk/418938/
Autor:
Kalita, Neelam, Harris, Petra B, Lord, Joanne, Frampton, Geoffrey, Scott, David A., Picot, Joanna
This report is a critique of the company’s submission (CS) to NICE from Pfizer on the clinical effectiveness and cost effectiveness of tofacitinib for moderately to severely active ulcerative colitis. It identifies the strengths and weakness of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______348::6920e953a9559a1a03412323c212b661
https://eprints.soton.ac.uk/437770/
https://eprints.soton.ac.uk/437770/
Autor:
Onyimadu, Oluchukwu, Lord, Joanne, Picot, Joanna, Cooper, Keith, Scott, David A., Shepherd, Jonathan
This report is a critique of the company’s submission (CS) to NICE from Roche Product Limited on the clinical effectiveness and cost effectiveness of atezolizumab in combination for non-squamous non-small-cell lung cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______348::0a2ea7477104a3b97b9b9ff21c1c92b4
https://eprints.soton.ac.uk/437767/
https://eprints.soton.ac.uk/437767/
Autor:
Cooper, Keith, Picot, Joanna, Onyimadu, Oluchukwu, Shepherd, Jonathan, Lord, Joanne, Scott, David A.
This report is a critique of the company’s submission (CS) to NICE from Bayer on the clinical effectiveness and cost effectiveness of rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease. It identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______348::4b6173ecaaf6245877123f66ad1127a8
https://eprints.soton.ac.uk/437769/
https://eprints.soton.ac.uk/437769/
Autor:
Cooper, Keith, Kalita, Neelam, Harris, Petra, Onyimadu, Oluchukwu, Gaisford, Wendy C, Picot, Joanna
The company’s submission (CS) reflects the scope of the appraisal issued by the National Institute for Health and Care Excellence (NICE). The submission assesses the clinical effectiveness and cost effectiveness of fulvestrant for untreated hormone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______348::4412b15fc8bb1f381727006616a2b640
https://eprints.soton.ac.uk/417748/
https://eprints.soton.ac.uk/417748/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.